← All organizations
Highest phase reached
Phase 3
First clinical trial
Sep 13, 2017Last known activity
Jan 15, 2026
Timeline
2010s
- Jun 1, 2013
InventisBio Inc.— Founded
Drugs by trial phase (11 distinct, 26 trials)
Phase 3 (3 own, 0 via acquisition)
Phase 2 (6 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Indications
Recent trials (27)
- NCT07311200Lead sponsorPhase 2Jan 15, 2026
- NCT07270783Lead sponsorPhase 1Dec 31, 2025
- NCT07130604Lead sponsorPhase 3Sep 26, 2025
- NCT07035041Lead sponsorPhase 2May 22, 2025
- NCT07275775Lead sponsorPhase 1Aug 13, 2024
- NCT06278350Lead sponsorPhase 2Feb 4, 2024
- NCT06233916Lead sponsorPhase 1Dec 8, 2023
- NCT06105255Lead sponsorPhase 1May 24, 2023
- NCT05665699Study directorPhase 2Feb 27, 2023
- NCT05665699Lead sponsorPhase 2Feb 27, 2023
- NCT06166836CollaboratorPhase 1/Phase 2Oct 12, 2022
- NCT05492045Lead sponsorPhase 1/Phase 2Sep 30, 2022
- NCT05379946Lead sponsorPhase 1/Phase 2Sep 30, 2022
- NCT06954961Lead sponsorPhase 3Sep 15, 2022
- NCT05504083Lead sponsorPhase 2Aug 25, 2022
Details
- Founded
- Shanghai, CN Jun 1, 2013
- Last known activity
- Jan 15, 2026